Nasdaq:US$14.77 (+0.11) | HKEX:HK$23.24 (+0.00) | AIM:£2.14 (-0.04)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate